Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation
World Neurosurgery · 2023
DOI: 10.1016/j.wneu.2023.08.092 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift World Neurosurgery, 2023. Verfasst von Aroosa Zamarud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Trigeminal Neuralgia, Radiosurgery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Trigeminal neuralgia (TN) is a paroxysmal, unilateral, brief, shock-like pain in ≥1 divisions of the trigeminal nerve. It can result from multiple causes; however, TN secondary to stroke is very rare. METHODS: We present the case of TN secondary to pontine infarction treated with incremental doses of neuropathic pain medication for >5 years before conservative management failed. He was then treated with stereotactic radiosurgery (SRS). Additionally, we conducted a systematic review using standard PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines for all the cases of TN with brainstem stroke from 1976 to 2022. RESULTS: Our patient was an 82-year-old man. Magnetic resonance imaging demonstrated a pontine lesion consistent with stroke. The Barrow Neurological Institute (BNI) score at presentation was 5. He received a marginal dose of 60 Gy to the 80% isodose line in a single fraction to a volume of 0.05 cm3. The immediate post-treatment BNI score was 0 and remained at 0 for 3 months, when he experienced recurrence. The recurrence was treated with oxcarbazepine. His pain remained well controlled with a lower dose of oxcarbazepine, and he had no adverse effects at 1 year of follow-up with a BNI score of 3. The systemic review identified 21 case reports with a combined cohort of 25 patients with TN secondary to stroke. Only 3 patients were treated with SRS, 2 of whom reported symptom improvement at 6 months and 8 months of follow-up with no adverse events. CONCLUSIONS: Our case and literature review demonstrate durable and effective treatment with SRS, which can be considered a safe and effective treatment option for patients with stroke-associated TN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA. Electronic address: ameola@stanford.edu.
Zitieren
APA
Zamarud, A., Park, D. J., Ung, T. H., McCleary, T. L., Yoo, K. H., Soltys, S. G., Lim, M., Chang, S. D., & Meola, A. (2023). Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation. World Neurosurgery. https://doi.org/10.1016/j.wneu.2023.08.092
Vancouver
Zamarud A, Park DJ, Ung TH, McCleary TL, Yoo KH, Soltys SG, et al. Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation. World Neurosurgery. 2023. doi:10.1016/j.wneu.2023.08.092
BibTeX
@article{Zamarud2023,
author = {Zamarud, Aroosa and Park, David J and Ung, Timothy H and McCleary, Tamra-Lee and Yoo, Kelly H and Soltys, Scott G and Lim, Michael and Chang, Steven D and Meola, Antonio},
title = {Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation},
journal = {World Neurosurgery},
year = {2023},
doi = {10.1016/j.wneu.2023.08.092}
}
EUVIMED